D-0488-2024 Class II Terminated
FDA drug recall D-0488-2024 was initiated by FDC Limited on Apr 25, 2024 and is designated Class II. Reason for recall: Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers. The recall status is terminated (terminated May 21, 2026). Affected quantity: 382,104 units.
Recall details
- Product Type
- Drugs
- Report Date
- May 15, 2024
- Initiation Date
- Apr 25, 2024
- Termination Date
- May 21, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 382,104 units
Product description
Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (NDC 64980-514-15), Rx only, Manufactured by: FDC Limited, Maharashtra, India, Distributed by: Rising Pharmaceuticals, Inc, NJ
Reason for recall
Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.
Distribution pattern
New Jersey Only
Code information
Lot #: a) 083H008, Exp. Date 07/2025; 083G003, Exp. Date 06/2025; 083J017, Exp. Date 09/2025; b) 083I013, Exp. Date 08/2025.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0488-2024
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026